Free Guide to Colorectal Cancer Screening from NCCN Now Available in More Than a Dozen Languages

National Comprehensive Cancer Network

PR95097

 

PLYMOUTH MEETING, Pa., Mar. 28, 2022 /PRNewswire=KYODO JBN/--

 

-- NCCN Guidelines for Patients: Colorectal Cancer Screening now translated

into multiple languages to help people worldwide understand why, when and how

to screen for colorectal cancer.

 

The National Comprehensive Cancer Network(R) (NCCN(R)) today announced new

translations (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3947862756&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fwhat-we-do%2Finternational-adaptations-and-translations%23guidelines-for-patients-translations&a=new+translations

) of the recently-published NCCN Guidelines for Patients(R): Colorectal Cancer

Screening (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=709243821&u=https%3A%2F%2Fwww.nccn.org%2Fhome%2Fnews%2FNewsDetails%3FNewsId%3D2996&a=Colorectal+Cancer+Screening

). This free resource—made possible through funding from the NCCN

Foundation(R)—is now accessible to patients and caregivers in Arabic, Chinese,

French, Haitian Creole, Hindi, Hmong, Italian, Japanese, Korean, Polish,

Portuguese, Russian, Spanish, Somali, Tagalog, and Vietnamese.

 

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

 

"The NCCN Foundation is committed to advancing cancer care so all patients can

live better lives, through funding for evidence-based, trustworthy sources of

medical information," said Patrick Delaney, Executive Director, NCCN

Foundation. "By translating this book into multiple languages, we are making

sure patients and caregivers everywhere can make shared decisions about the

right screening fit for them."

 

Experts are now recommending that colorectal cancer screening begin at age 45

years for people at average risk, and even younger for some in higher risk

groups. Access to accurate information on cancer screening is particularly

needed right now, as the COVID-19 pandemic has led to a decrease in timely

cancer screening and diagnoses—and is projected to result in more later-stage

cases. Learn more about how "Cancer Won't Wait and Neither Should You" at

NCCN.org/resume-screening (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=1010205405&u=https%3A%2F%2Fwww.nccn.org%2Fcovid-19%2Fresume-screening&a=NCCN.org%2Fresume-screening

).

 

"Colorectal cancer screening is an incredibly effective tool for improving

outcomes and even preventing this commonly-occurring cancer," said Anjee Davis,

MPPA, President of Fight Colorectal Cancer (Fight CRC). "Screening can reduce

the rate of death by detecting CRC at an earlier, more treatable stage, and can

reduce overall cancer incidences by finding and removing pre-cancerous polyps.

We're happy that this essential information is now accessible for even more

people around the world."

 

Free digital versions of the NCCN Guidelines for Patients: Colorectal Cancer

Screening are available at NCCN.org/patientguidelines (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=4122081717&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=NCCN.org%2Fpatientguidelines

) and via the NCCN Patient Guides for Cancer App (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=254189018&u=https%3A%2F%2Fwww.nccn.org%2Fguidelines%2Fnccn-mobile-app&a=NCCN+Patient+Guides+for+Cancer+App

). The growing library of NCCN Guidelines for Patients includes more than 60

frequently-updated books for patients and caregivers covering most major types

of cancer, including colon (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=130693573&u=https%3A%2F%2Fwww.nccn.org%2Fpatientresources%2Fpatient-resources%2Fguidelines-for-patients%2Fguidelines-for-patients-details%3FpatientGuidelineId%3D8&a=colon

) and rectal (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3470203465&u=https%3A%2F%2Fwww.nccn.org%2Fpatientresources%2Fpatient-resources%2Fguidelines-for-patients%2Fguidelines-for-patients-details%3FpatientGuidelineId%3D36&a=rectal

) cancers, as well as supportive care and survivorship recommendations.

 

The evidence-based, expert-vetted NCCN Guidelines for Patients contain the same

information as the NCCN Clinical Practice Guidelines in Oncology (NCCN

Guidelines(R))—the recognized standard for clinical direction and policy in

cancer care and the most thorough and frequently updated clinical practice

guidelines available in any area of medicine. The patient versions are

presented in an easy-to-read format—with charts, images, and a glossary of

medical terms. There are now more than 50 translated versions of NCCN

Guidelines for Patients available.

 

Learn more and help support these and other resources for people with cancer

and their caregivers at NCCN.org/patients (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3119278862&u=https%3A%2F%2Fwww.nccn.org%2Fpatientresources%2Fpatient-resources%2Fnccn-foundation%2Fabout-and-contact&a=NCCN.org%2Fpatients

).

 

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN(R)) is a not-for-profit

alliance of leading cancer centers (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=2852415688&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=leading+cancer+centers

) devoted to patient care, research, and education. NCCN is dedicated to

improving and facilitating quality, effective, equitable, and accessible cancer

care so all patients can live better lives. Visit: NCCN.org (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3342274603&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN.org

) for more information on the NCCN Clinical Practice Guidelines in Oncology

(NCCN Guidelines(R) (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=102386836&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines

)) and other initiatives. Follow NCCN on Facebook @NCCNorg (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=186975152&u=http%3A%2F%2Fwww.facebook.com%2FNCCNorg&a=%40NCCNorg

), Instagram @NCCNorg (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=2883410020&u=https%3A%2F%2Fwww.instagram.com%2Fnccnorg%2F&a=%40NCCNorg

) and Twitter @NCCN (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3616737874&u=http%3A%2F%2Fwww.twitter.com%2Fnccn&a=%40NCCN

).

 

About the NCCN Foundation

The NCCN Foundation(R) was founded by the National Comprehensive Cancer

Network(R) (NCCN(R)) to empower people with cancer and advance oncology

innovation. The NCCN Foundation empowers people with cancer and their

caregivers by delivering unbiased expert guidance from the world's leading

cancer experts through the library of NCCN Guidelines for Patients(R) and other

patient education resources. The NCCN Foundation is also committed to advancing

cancer treatment by funding the nation's promising young investigators at the

forefront of cancer research. For more information about the NCCN Foundation,

visit: NCCN.org/foundation (

https://c212.net/c/link/?t=0&l=en&o=3477036-1&h=3542367778&u=http%3A%2F%2Fwww.nccn.org%2Ffoundation&a=NCCN.org%2Ffoundation

).

 

Media Contact:

Rachel Darwin

+1-267-622-6624

darwin@nccn.org

 

SOURCE: National Comprehensive Cancer Network

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中